news
Nemus Bioscience’s cannabis drug treats glaucoma in animal models
Nemus Bioscience announced that THC derived from NB1111 achieved significant tissue concentrations in multiple compartments of the eye...
List view / Grid view
Nanoparticles
news
Extra funding for nanomaterials for cancer immunotherapy research
The DFG has agreed to fund the Mainz-based Collaborative Research Center involved in the development of nanomaterials for cancer immunotherapy...
news
New blood test uses nanotechnology to predict prostate cancer
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
news
Nanoparticle aggregates for destruction of cancer cells
An international team has shown that it is possible to mechanically destroy cancer cells by rotating magnetic nanoparticles attached to them in elongated aggregates.
news
Anticancer nanomaterials created by simulating underwater volcanoes
Researchers at Aalto University, Finland, have developed anticancer nanomaterials by simulating the volcano-induced dynamic chemistry of the deep ocean.
article
A new approach to Organ-on-a-Chip
Draper's Joe Charest explains how synthetic organoids can lead to safer drug testing, and why organ-on-a-chip technology is the future of drug discovery...
article
Nanoparticle-mediated enzyme delivery for application in cancer therapy
Enzyme therapy is a promising form of cancer treatment. The specific nature of enzyme and substrate interaction gives enzyme therapy an edge compared to standard non-specific therapies such as radiation and chemotherapy. However, since most of these enzymes are of a foreign nature, the delivery of these immunogenic enzymes has…
news
Nanoinjection increases survival rate of cells to 90%
How do tumours grow? And how do bacteria transform harmless substances into medical agents? When biophysicists want to understand what is happening in living cells, they have to introduce fluorescent probes or other foreign molecules. There are several ways to overcome the cell wall without causing the cell permanent harm.
news
Nanohyperthermia softens tumours to improve treatment
The mechanical resistance of tumours and collateral damage of standard treatments often hinder efforts to defeat cancers.
news
Magnetically controlled drug effectively targets and dissolves blood clots
23 June 2016 | By Victoria White, Digital Content Producer
Scientists have developed a magnetically controlled drug that can be condensed on a blood clot by means of a magnetic field...
news
Nanoparticles used to deliver RNAi agents to thyroid cancer tumours
20 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed an innovative nanoplatform that allows them to effectively deliver RNAi agents to the sites of cancer and suppress tumour growth...
news
Nanoparticles hold promise in the fight against genital herpes
28 April 2016 | By Victoria White, Digital Content Producer
Researchers have shown that zinc-oxide nanoparticles can prevent genital herpes virus from entering cells, and help natural immunity to develop...
news
Nanoparticles show promise for treating inflammatory bowel disease
8 April 2016 | By Victoria White
Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease...
news
New nanoparticle has potential to treat ocular cancer
19 February 2016 | By Victoria White
Researchers have developed a new nanoparticle that uses a tumour cell's protective mechanism against itself - short-circuiting tumour cell metabolism and killing tumour cells...
article
Drug Target Review’s top 10 stories from 2015
28 January 2016 | By Victoria White, Digital Content Producer, Drug Target Review
2015 was an exciting year for the drug discovery industry. Here we look at a selection of stories that particularly stood out for us…
